{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:12:53Z","timestamp":1779289973148,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.amjmed.2005.06.012","type":"journal-article","created":{"date-parts":[[2005,12,27]],"date-time":"2005-12-27T09:28:19Z","timestamp":1135675699000},"page":"1416.e9-1416.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors"],"prefix":"10.1016","volume":"118","author":[{"given":"Peter K.","family":"Wung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet T.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea K.","family":"Tibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-I.","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Spiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. William","family":"St. Clair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"McCune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Ytterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2005.06.012_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice. Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib2","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V74.4.1424.1424","article-title":"Herpes zoster infection after autologous bone marrow transplantation","volume":"74","author":"Schuchter","year":"1989","journal-title":"Blood."},{"key":"10.1016\/j.amjmed.2005.06.012_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes zoster infection following solid organ transplantation","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant."},{"key":"10.1016\/j.amjmed.2005.06.012_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/infdis\/166.5.1153","article-title":"Herpes zoster and human immunodeficiency virus infection","volume":"166","author":"Buchbinder","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2005.06.012_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.amjmed.2005.06.012_bib6","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/S0264-410X(03)00034-3","article-title":"The incidence of shingles and its implications for vaccination policy","volume":"21","author":"Chapman","year":"2003","journal-title":"Vaccine."},{"key":"10.1016\/j.amjmed.2005.06.012_bib7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2005.06.012_bib8","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant-cell granuloma of the respiratory tract (Wegener\u2019s granulomatosis)","volume":"34","author":"Walton","year":"1958","journal-title":"Br Med J."},{"key":"10.1016\/j.amjmed.2005.06.012_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener\u2019s granulomatosis","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept in addition to standard therapy in patients with Wegener\u2019s granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0002-9343(80)80014-3","article-title":"Herpes zoster in patients with treated Wegener\u2019s granulomatosis. A possible role for cyclophosphamide","volume":"69","author":"Cupps","year":"1980","journal-title":"Am J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib14","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener\u2019s granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM197112302852701","article-title":"Effect of cyclophosphamide upon the immune response in Wegener\u2019s granulomatosis","volume":"285","author":"Fauci","year":"1971","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0889-857X(05)70240-4","article-title":"Treatment of Wegener\u2019s granulomatosis","volume":"27","author":"Regan","year":"2001","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.amjmed.2005.06.012_bib17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","article-title":"A staged approach to the treatment of Wegener\u2019s granulomatosis","volume":"42","author":"Langford","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib19","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/1529-0131(200008)43:8<1836::AID-ANR20>3.0.CO;2-R","article-title":"Use of methotrexate and glucocorticoids in the treatment of Wegener\u2019s granulomatosis. Long-term renal outcome in patients with glomerulonephritis","volume":"43","author":"Langford","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib20","first-page":"1134","article-title":"Treatment of non-life threatening Wegener\u2019s granulomatosis with methotrexate and daily prednisone as the initial therapy of choice","volume":"26","author":"Stone","year":"1999","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.06.012_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0197-2456(02)00209-X","article-title":"Design of the Wegener\u2019s granulomatosis etanercept trial (WGET)","volume":"23","year":"2002","journal-title":"Control Clin Trials."},{"key":"10.1016\/j.amjmed.2005.06.012_bib22","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener\u2019s granulomatosis","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib25","unstructured":"National Cancer Institute. Toxicity Grading Scale 1982. Available at: http:\/\/ctep.info.nih.gov. Accessed October 7, 2005."},{"key":"10.1016\/j.amjmed.2005.06.012_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","article-title":"Postherpetic neuralgia\u2014pathogenesis, treatment, and prevention","volume":"335","author":"Kost","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(99)70398-1","article-title":"Varicella zoster virus","volume":"41","author":"McCrary","year":"1999","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.amjmed.2005.06.012_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.amjmed.2005.06.012_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.amjmed.2005.06.012_bib30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1600-6143.2004.00505.x","article-title":"Cytomegalovirus and lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am J Transplant."},{"key":"10.1016\/j.amjmed.2005.06.012_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11908-004-0068-4","article-title":"Illness of immune reconstitution","volume":"6","author":"Gardner","year":"2004","journal-title":"Curr Infect Dis Rep."},{"key":"10.1016\/j.amjmed.2005.06.012_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1086\/320884","article-title":"Characteristics of patients with herpes zoster on presentation to practitioners in France","volume":"33","author":"Chidiac","year":"2001","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.amjmed.2005.06.012_bib34","first-page":"84","article-title":"Herpes zoster infections in systemic lupus erythematosus","volume":"21","author":"Kahl","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.amjmed.2005.06.012_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/art.1780210710","article-title":"Herpes zoster in patients with systemic lupus erythematosus","volume":"21","author":"Moutsopoulos","year":"1978","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.amjmed.2005.06.012_bib36","first-page":"1254","article-title":"Herpes zoster in systemic lupus erythematosus","volume":"22","author":"Manzi","year":"1995","journal-title":"J Rheumatol.f"},{"key":"10.1016\/j.amjmed.2005.06.012_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9343(91)80008-A","article-title":"Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate","volume":"90","author":"Antonelli","year":"1991","journal-title":"Am J Med."},{"key":"10.1016\/j.amjmed.2005.06.012_bib38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/315146","article-title":"Zoster incidence in human immunodeficiency virus-infected hemophiliacs and homosexual men, 1984-1997. District of Columbia Gay Cohort Study. Multicenter Hemophilia Cohort Study","volume":"180","author":"Engels","year":"1999","journal-title":"J Infect Dis."},{"key":"10.1016\/j.amjmed.2005.06.012_bib39","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00002030-199510000-00006","article-title":"Herpes zoster, immunological deterioration and disease progression in HIV-1 infection","volume":"9","author":"Veenstra","year":"1995","journal-title":"AIDS."},{"key":"10.1016\/j.amjmed.2005.06.012_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmv.1890270209","article-title":"Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster","volume":"27","author":"Webster","year":"1989","journal-title":"J Med Virol."},{"key":"10.1016\/j.amjmed.2005.06.012_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/jcm.12.3.367-374.1980","article-title":"Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay","volume":"12","author":"Arvin","year":"1980","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.amjmed.2005.06.012_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/smim.2001.0293","article-title":"Immune evasion as a pathogenic mechanism of varicella zoster virus","volume":"13","author":"Abendroth","year":"2001","journal-title":"Semin Immunol."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934305004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:40:04Z","timestamp":1757580004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934305004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002934305004456"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.06.012","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2005.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}